IntuiTap Medical

Executive Summary

IntuiTap Medical is addressing the high failure rate and complications of lumbar punctures through its VerTouch device, which provides real-time 2D anatomical mapping to replace traditional palpation. By improving first-attempt success and reducing the need for fluoroscopy, the technology aims to enhance patient safety and lower healthcare costs. The company targets emergency departments, neurology, and anesthesiology settings where spinal taps are performed frequently. With a strong intellectual property position and initial positive feedback from early adopters, IntuiTap is well-positioned to disrupt a procedure that has seen little innovation despite its widespread use. The global lumbar puncture market is sizable, and VerTouch’s value proposition is compelling for hospitals seeking to reduce procedure times and complications. The company is currently in the commercialization phase, focusing on regulatory clearances and building clinical evidence to support adoption.

Upcoming Catalysts (preview)

• Q4 2026FDA 510(k) Clearance for VerTouch70% success
• Q2 2027Publication of Pivotal Clinical Study Results60% success
• Q3 2026Strategic Partnership with Major Hospital Network or Distributor50% success